Los Angeles, Calif.–(Newsfile Corp. – August 4, 2022) – Schall law firma national shareholder rights litigation firm, reminds investors of a class action lawsuit against Outset Medical, Inc. (“Outset” or “the Company”) (NASDAQ: OM) for violations of §§10(b) and 20 (a) the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the United States Securities and Exchange Commission.
Investors who purchased the Company’s securities between September 15, 2020 and June 13, 2022 inclusive (the “Class Period”) are invited to contact the Company before September 6, 2022.
If you are a shareholder who has suffered a loss, Click here to participate.
We also encourage you to contact Brian Schall of Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us via the firm’s website at www.schallfirm.comor by e-mail to [email protected]
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to do nothing, you can remain an absent member of the group.
According to the complaint, the company made false and misleading statements to the market. Outset required an additional 510(k) application due to having “continually made improvements and updates to Tablo over the time since its initial authorization”. The Company could not conduct a human factors study using a device cleared under FDA protocols. The company’s failure to complete a human factors study was likely to lead the FDA to suspend shipping and market the Tablo product. Based on these facts, the Company’s public statements were false and materially misleading throughout the Class Period. When the market learned the truth about Outset, investors suffered damage.
Join the file to recoup your losses.
Schall Law Firm represents investors worldwide and specializes in securities class action and shareholder rights litigation.
This press release may be considered attorney advertising in certain jurisdictions under applicable law and ethics rules.
CONTACT:
Schall law firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
[email protected]
THE SOURCE:
Schall law firm
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/132840
